BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28916426)

  • 1. Prognostic relevance of tripartite motif containing 24 expression in colorectal cancer.
    Wang FQ; Han Y; Yao W; Yu J
    Pathol Res Pract; 2017 Oct; 213(10):1271-1275. PubMed ID: 28916426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gab2 is a novel prognostic factor for colorectal cancer patients.
    Ding C; Luo J; Yu W; Gao S; Yang L; Chen C; Feng J
    Int J Clin Exp Pathol; 2015; 8(3):2779-86. PubMed ID: 26045784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Rab27A expression indicates favorable prognosis in CRC.
    Shi C; Yang X; Ni Y; Hou N; Xu L; Zhan F; Zhu H; Xiong L; Chen P
    Diagn Pathol; 2015 Jun; 10():68. PubMed ID: 26070933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of INF-induced transmembrane protein 1 in colorectal cancer.
    He J; Li J; Feng W; Chen L; Yang K
    Int J Clin Exp Pathol; 2015; 8(12):16007-13. PubMed ID: 26884876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low expression of RASSF10 is associated with poor survival in patients with colorectal cancer.
    Wang F; Li P; Feng Y; Hu YL; Liu YF; Guo YB; Jiang XL; Mao QS; Xue WJ
    Hum Pathol; 2017 Apr; 62():108-114. PubMed ID: 28041974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partner of Sld five 3: a potential prognostic biomarker for colorectal cancer.
    Sun X; Sui W; Huang M; Wang Y; Xuan Y; Wang Z
    Diagn Pathol; 2014 Nov; 9():217. PubMed ID: 25403684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer.
    Duncan TJ; Watson NF; Al-Attar AH; Scholefield JH; Durrant LG
    World J Surg Oncol; 2007 Mar; 5():31. PubMed ID: 17349047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpressed Rce1 is positively correlated with tumor progression and predicts poor prognosis in prostate cancer.
    Huang L; Li M; Wang D; He J; Wu W; Zeng Q; Li J; Xiao M; Hu J; He Y; Li Y; Mai L; Liu W
    Hum Pathol; 2016 Jan; 47(1):109-14. PubMed ID: 26546252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance and prognostic value of TRIM24 expression in esophageal squamous cell carcinoma.
    Chi J; Yang Q; Xie XF; Yang XZ; Zhang MY; Wang HY; Xu GL
    Aging (Albany NY); 2016 Sep; 8(9):2204-2221. PubMed ID: 27689360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of stromal GREM1 expression in colorectal cancer.
    Jang BG; Kim HS; Chang WY; Bae JM; Oh HJ; Wen X; Jeong S; Cho NY; Kim WH; Kang GH
    Hum Pathol; 2017 Apr; 62():56-65. PubMed ID: 28041973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
    Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
    Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KIF2A overexpression and its association with clinicopathologic characteristics and unfavorable prognosis in colorectal cancer.
    Fan X; Wang X; Zhu H; Wang W; Zhang S; Wang Z
    Tumour Biol; 2015 Nov; 36(11):8895-902. PubMed ID: 26070867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tripartite motif containing 24 regulates cell proliferation in colorectal cancer through YAP signaling.
    Xie W; Zhang Y; Wang B; Hu Y; Zhan B; Wei F; Tang J; Lian J
    Cancer Med; 2020 Sep; 9(17):6367-6376. PubMed ID: 32677374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIM24 is upregulated in human gastric cancer and promotes gastric cancer cell growth and chemoresistance.
    Miao ZF; Wang ZN; Zhao TT; Xu YY; Wu JH; Liu XY; Xu H; You Y; Xu HM
    Virchows Arch; 2015 May; 466(5):525-32. PubMed ID: 25724180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of Rab5A predicts metastasis and poor prognosis in colorectal cancer patients.
    Yu MH; Luo Y; Qin SL; Zhong M
    Int J Clin Exp Pathol; 2015; 8(6):6974-80. PubMed ID: 26261586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
    Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
    Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semaphorin 4D and hypoxia-inducible factor-1α overexpression is related to prognosis in colorectal carcinoma.
    Wang JS; Jing CQ; Shan KS; Chen YZ; Guo XB; Cao ZX; Mu LJ; Peng LP; Zhou ML; Li LP
    World J Gastroenterol; 2015 Feb; 21(7):2191-8. PubMed ID: 25717256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression of dual specificity phosphatase 22 in colorectal cancer and its potential prognostic relevance for stage IV CRC patients.
    Yu D; Li Z; Gan M; Zhang H; Yin X; Tang S; Wan L; Tian Y; Zhang S; Zhu Y; Lai M; Zhang D
    Tumour Biol; 2015 Nov; 36(11):8531-5. PubMed ID: 26032091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of Hes1 expression is associated with poor prognosis in colorectal adenocarcinoma.
    Ahadi M; Andrici J; Sioson L; Sheen A; Clarkson A; Gill AJ
    Hum Pathol; 2016 Nov; 57():91-97. PubMed ID: 27476040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD133 expression is correlated with poor prognosis in colorectal cancer.
    Kashihara H; Shimada M; Kurita N; Iwata T; Sato H; Kozo Yoshikawa ; Higashijima J; Chikakiyo M; Nishi M; Matsumoto N
    Hepatogastroenterology; 2014 Sep; 61(134):1563-7. PubMed ID: 25436343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.